Kewaunee Scientific (NASDAQ:KEQU) Shares Pass Above 200 Day Moving Average of $16.55

Kewaunee Scientific Co. (NASDAQ:KEQU) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $16.55 and traded as high as $18.43. Kewaunee Scientific shares last traded at $18.06, with a volume of 187 shares changing hands.

Wall Street Analyst Weigh In

Separately, TheStreet upgraded Kewaunee Scientific from a “c+” rating to a “b-” rating in a research report on Thursday, August 31st.

Kewaunee Scientific Price Performance

The firm has a market cap of $53.53 million, a PE ratio of 13.55 and a beta of 0.29. The stock’s fifty day moving average price is $17.98 and its 200-day moving average price is $16.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 2.11 and a quick ratio of 1.61.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Thursday, August 31st. The technology company reported $0.86 earnings per share (EPS) for the quarter. The company had revenue of $49.84 million during the quarter. Kewaunee Scientific had a net margin of 1.81% and a return on equity of 10.53%.

Insider Activity

In other news, VP Elizabeth D. Phillips sold 1,557 shares of the company’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $17.56, for a total value of $27,340.92. Following the transaction, the vice president now owns 14,035 shares of the company’s stock, valued at approximately $246,454.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 14.50% of the company’s stock.

Hedge Funds Weigh In On Kewaunee Scientific

Institutional investors have recently modified their holdings of the business. BlackRock Inc. grew its stake in Kewaunee Scientific by 58.2% during the 2nd quarter. BlackRock Inc. now owns 13,102 shares of the technology company’s stock worth $198,000 after purchasing an additional 4,822 shares in the last quarter. Minerva Advisors LLC grew its position in shares of Kewaunee Scientific by 1.4% during the first quarter. Minerva Advisors LLC now owns 172,919 shares of the technology company’s stock worth $2,730,000 after buying an additional 2,378 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Kewaunee Scientific by 1.3% during the first quarter. Vanguard Group Inc. now owns 126,581 shares of the technology company’s stock worth $1,836,000 after buying an additional 1,683 shares during the period. Dimensional Fund Advisors LP lifted its stake in Kewaunee Scientific by 0.4% in the third quarter. Dimensional Fund Advisors LP now owns 185,989 shares of the technology company’s stock worth $3,273,000 after acquiring an additional 742 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Kewaunee Scientific by 0.7% during the 2nd quarter. Renaissance Technologies LLC now owns 98,111 shares of the technology company’s stock worth $1,631,000 after acquiring an additional 700 shares in the last quarter. Institutional investors and hedge funds own 32.98% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.